All good, brother. It’s entirely human to take personal

New Post Public Reply Private Reply Replies (3) Message Board
andyandred Evil Rabbit #68894
1,055
All good, brother. It’s entirely human to take personal ire to a public (or semi-public) forum these days. We live in an outrage culture online, and it’s better than taking it out on our family or friends. It’s healthy to vent. I guess my point is also just that it’s all tied to personal choices, and we are not victims here. I’ll bet if you had the foresight to sell all or a lot of your position on the $10 run-up in the summer (and I’m sure in hindsight you wish you had), and then you watched the share price plummet, you would feel like a genius and not so much like an idiot or a victim of shorts or NP or CytoDyn. You’d be excited to see the value of the company keep falling because you just made a ton of realized cash on this stock, and you want to buy back in with the house’s money at a lower or the lowest point. And then if you held off taking a position again till a few weeks ago when it hit $1.65 a share and you said to yourself: “this is the bottom, I getting my position back”, and the price then started to climb right after you bought back in, and it never sees that price ever again, all your foresight and tactical maneuvering would have made you feel very very differently about this stock and this company and its CEO these past 6 months. So your criticism of NP or dismay of the stock price drop, albeit certainly justified at times, isn’t entirely objective criticism nor is it really shared in service to the shareholder community; it’s just an emotional reaction to your stock portfolio and you need to point the finger away from yourself because you didn’t play sell/buy orders like a master trader. And I just believe that the mentality of accountability (not victimhood), and the underlying motivation of our communication is vital to not only the success of your communities, but also own personal growth and relationship with our own emotions and self-awareness. And when I’m “investing” in a company and product I believe as a result of rigorous due diligence, and I’m not just reading a stick to turn around some quick cash, then I try not to fret the stock volatility over any given day, week, month, or even year because it’s a long-term investment that I don’t worry about in that capacity; I may merely watch the share price when seeking opportunities to accumulate more shares in a dip or drop.

And when investors have an average share price of less than $1, which I assume you have if you have been critical of NP for over 3 years, I think it’s somewhat ungrateful to publicly complain about a company that has managed to get you in the black and keep you there for almost a year. I can appreciate it’s a vacillating scale, and it can be important to remain critical no matter the underlying financial circumstances, be it in the red or black (since evolution and growth of the company are the goal), but, from a data standpoint (using the share price as a measurement), there is more evidence to suggest our team is very good at what they do, and it’s wise to retain gratitude and perspective of that, especially when all the criticism is used more as emotional catharsis or blaming & shaming, and not as a constructive tool for the people we’re complaining about to grow from... we have their emails and can presents comments & questions on conference call - that is when the criticism is being used to try to improve and better understand the situation, and not just vent in a method that can poison the well in ways that only hurt the very thing you’re trying to protect & improve - the share price. And I think investors that post multiple times per day almost every day can lose perspective more easily, grow too obsessed, and they need to be able to step back entirely for weeks or longer, usually when negative emotions are running high, because if you don’t plan to buy or sell for a while, why bother to track and engage in something that is just causing stress and dismay? Regaining some objectivity and not getting too in the weeds with something we can’t ultimately control and we choose not to directly interface with the company management but merely comment in ways that they can’t see, that presents some warning signs that seasoned investors usually self-check and self-correct.

I can certainly come off like I’m lecturing, I get that. I just, at times, like to step in with some added perspective, which may sound judgmental or critical, but my tone can’t really be grasp in the written language as well as in voice, and my intent is to implore consistent posters, who often bash, to just ask how effective it is for the group, if it is serving their own investment, and is there more of an emotional/financial component that is driving the concern that wouldn’t be as strong or present if they were in a different position. Basically, it is being selfish or selfless by communicating that and in that way.

The interesting thing about investing in a company is that when we’re invested, we hate negative action on the stock price, but when we’re not and looking to get in or re-enter, we like the negative action and get nervous when the stock is going up and making in more expensive to get in or accumulate more. So I just think if investors truly believe in the science of this product, and the fact the company has rescued it from bankruptcy and got it to its most secure position to date, there is thus no need to risk putting cracks in the dams and publicly criticizing the company in ways that the company can’t use the feedback to grow. Call or email Nader when there’s issues; he’s accessible. And if the emotions are running too high and venting is necessary, and it needs to be done online among people who will get the context, then preface a public complaints with: I get this just me playing the victim right now because I’m mostly bummed my investment is down, and I do believe in this investment and I ultimately trust our leadership, but this is how I’m currently feeling and I need to say this ... (insert complaint / bash / criticism). Proper context and being accountable for our decisions and words is the truly healthy approach to investing, especially in investments with public online communities, and no one is forced to invest and no stock doesn’t fluctuate in value (just look a Tesla there last few years). And I do believe that victim mentalities don’t get rewarded, and they cause poor decisions to be made that one usually regrets if they become to pervasive and lead to actions being taken, so it’s wise to be mindful of when that mindset has taken hold and caused public outrage. I personally have very small CYDY groups over less than 10 people who have rules about confidentiality who we chat most openly with. That’s a safe and healthy environment to exercise the human emotions while not risking setting sell-offs from inexperienced and nervous investors who use online chatter from strangers to make their decisions, or triggering fodder for shorts to attack. I recommending starting a tight group you trust for those purposes, as these forums with 1000s of people are a dangerous place to get all uppity about our investment woes if you’re trying to protect the stock value.

Now that I’ve fed my proverbial horse, I’ll go walk my literal dog I’ll see all the resilient longs at the reunion in 2025 when we pull up to the private island in our yachts and we reminisce about all our online antics, and we also express our gratitude for a company that saved lives and made us rich in our bank accounts and our souls. GLTA.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 4

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 2

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
Sotheby's to Auction Largest Flawless Paraiba Tourmalines

Updated Category News Views 0

Jaw-Dropping Gemstones Poised for Auction Glory The art of gemology isn't just about shiny rocks; it's a concoction of beauty, rarity, and, most importantly, value. And when the world's finest stones hit the auction block, it's akin to an epic performance in a long-awaited drama. On September 17, 2026, these precious Paraiba Tourmalines, fashioned by the adept hands of...

Continue Reading
AI Platform Suno Sued for Exploiting Artists' Identities

Updated Category News Views 1

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Continue Reading
AEON's AI-Powered Agentic Checkout: A Game Changer?

Updated Category News Views 3

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

Continue Reading
Baseus Debuts Innovations at IFA 2026: Earbuds to Security

Updated Category News Views 2

Baseus Pumps New Blood into Tech Gadgets Well, if you're looking for some fresh tech pumping in from Berlin, Baseus tossed out some intriguing gizmos at IFA 2026 that'll perk up your ears. We're looking at an evolution from a brand that's clawed its way from everyday accessories to a full-blown tech ecosystem—pretty ambitious, if you ask me. Baseus isn't playing small...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 1

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
Windows Storage Trends Shift: SSD Dominates 2026

Updated Category News Views 2

SSDs Take Center Stage in Storage Evolution Howdy, storage folks! It's 2026, and one thing's for sure—SSDs are strutting their stuff at the top of the storage heap. According to the latest report by EaseUS Software, the dominant drive isn't about sheer size anymore. We've moved on to smarter space management. Now hear this: 79.73% of Windows system drives are rocking...

Continue Reading
Beko's Innovations in Appliances: Practical Gains Measured

Updated Category News Views 3

Finding Efficiency in Everyday Routines Let’s kick things off with a no-nonsense look at Beko's thrust into the heart of day-to-day living. This isn’t about bells and whistles, folks—it's about delivering real, quantifiable improvements in how appliances serve us at home. Istanbul's latest reveal is a nod to practicality. From the onset, Beko wraps its hands around...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Partnership to Transform U.S. Data Center Energy Solutions

Updated Category News Views 111

Transforming Energy Solutions for Data Centers Engine No. 1 and Chevron U.S.A. Inc. (NYSE: CVX) have embarked on a groundbreaking partnership to reshape the energy landscape for data centers across the United States. This collaboration marks a significant step towards harnessing the country’s natural gas resources to create scalable and reliable power solutions for the...

Continue Reading
Tree Island Steel Announces Key Leadership Change with Director Retirement

Updated Category News Views 154

Significant Leadership Transition at Tree Island Steel Tree Island Steel Ltd. (TSX: TSL) has made a notable announcement regarding a transition in its leadership team. Ted Leja, a dedicated member of the Company’s board of directors, has stepped down from his position. This decision marks the end of an era, as Mr. Leja has been actively involved in the Company for more...

Continue Reading
Weyerhaeuser Ramps Up Support for Oregon Firefighters

Updated Category News Views 1

Combating Oregon's Fires: A Bold Initiative Weyerhaeuser's latest push to tackle the infernos that lick at Oregon's forests isn't some half-baked PR stunt. It's the real deal, built on the backbone of a five-year streak of tangible action — Fighting Fires Together. This year, they're diving deeper in the trenches, bolstering grants, partnerships, and resources for rural...

Continue Reading
Akeso's Global Strategy for Innovative Drug Development Unveiled

Updated Category News Views 279

Unveiling Akeso's Innovative Drug Development Strategy Akeso, Inc. is set to showcase its global strategy for new drug development at the esteemed J.P. Morgan Healthcare Conference. This event is noteworthy in the healthcare industry and offers a platform for Akeso to express its commitment to pioneering advancements in biopharmaceuticals. Participation in the J.P. Morgan...

Continue Reading
Trump and Putin's Recent Summit: Hopes and Challenges Ahead

Updated Category News Views 270

Trump and Putin's Meeting: An Overview Recently, a high-profile meeting took place between U.S. President Donald Trump and Russian President Vladimir Putin. Although both leaders characterized the discussions as productive, they concluded without reaching an agreement to halt or pause the ongoing war in Ukraine. This summit, lasting nearly three hours at an undisclosed...

Continue Reading